Pharmacogenomics of oral antiplatelet drugs.

about

Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.

P2860

Q38974781-8CC923CB-F600-4C4A-8B62-FDACE71FD7B1

P2860

Pharmacogenomics of oral antiplatelet drugs.

Item

http://www.wikidata.org/entity/Q38195628

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pharmacogenomics of oral antiplatelet drugs.

@en

type

Item

label

Pharmacogenomics of oral antiplatelet drugs.

@en

prefLabel

Pharmacogenomics of oral antiplatelet drugs.

@en

P1476

Pharmacogenomics of oral antiplatelet drugs

@en

P2093

Anthonius de Boer

http://www.w3.org/2001/XMLSchema#string

Olaf H Klungel

http://www.w3.org/2001/XMLSchema#string

Vera H M Deneer

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el

Variation in eicosanoid genes, non-fatal myocardial infarction and ischemic stroke.

The gain-of-function variant allele CYP2C19*17: a double-edged sword between thrombosis and bleeding in clopidogrel-treated patients

Anti-platelet therapy: phosphodiesterase inhibitors.

Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms

PlA polymorphism and platelet reactivity following clopidogrel loading dose in patients undergoing coronary stent implantation

807 C/T Polymorphism of the glycoprotein Ia gene and pharmacogenetic modulation of platelet response to dual antiplatelet treatment

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Cyclooxygenase-1 haplotype modulates platelet response to aspirin

P304

509-528

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS.14.16

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alfi Yasmina

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24624918

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics

Pharmacogenomics of oral antiplatelet drugs.

about

P2860

P2860

Pharmacogenomics of oral antiplatelet drugs.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921